Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety of Xeloda in Solid Tumours

NCT02479217 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT02479217
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02479217 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety of Xeloda in Solid Tumours
Lead sponsor
Hoffmann-La Roche
Phase
Observational
Overall status
Completed
Start date
July 31, 2006
Completion date
June 30, 2009
Enrollment
1,268 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic breast cancer, colon cancer